2251 - 2275 of 9156 Results
Title
Year
-
RESTRICTEDTitle: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glandsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 825Issue #:Start Page: 137702End Page: 137702Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10942751Citation Count: 0
-
OPENTitle: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1αJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 2Start Page: 238End Page: 252.e7Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028Best OA location URL: http://www.cell.com/article/S1097276517310079/pdfCitation Count: 165
-
OPENTitle: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 548End Page: 558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1Best OA location URL: https://research.vumc.nl/en/publications/57d02919-2cda-42ec-b013-51bcf8175201Citation Count: 130
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study2018RESTRICTEDTitle: Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 165End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30391-0Citation Count: 109
-
OPENTitle: White Matter Hyperintensities Related to Parkinson's Disease Executive FunctionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 629End Page: 638Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.12956Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12956Citation Count: 53
-
OPENTitle: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00064Best OA location URL: https://doi.org/10.3389/fnmol.2018.00064Citation Count: 38
-
OPENTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 164
-
OPENTitle: ToolBox: Live Imaging of intracellular organelle transport in induced pluripotent stem cell‐derived neuronsJournal Name: TrafficPublisher: WileyVol: 21Issue #: 1Start Page: 138End Page: 155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/tra.12701Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tra.12701Citation Count: 57
-
OPENTitle: Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1156End Page: 1163Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.07.025Best OA location URL: http://hdl.handle.net/11392/2334532Citation Count: 50
-
OPENTitle: Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinIONJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 7Issue #: 3Start Page: e564End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.564Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.564Citation Count: 94
-
OPENTitle: Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102600End Page: 102600Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102600Best OA location URL: https://doi.org/10.1016/j.scr.2021.102600Citation Count: 0
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 15
-
OPENTitle: Impact of antibiotics on smell dysfunctionJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 4Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.wjorl.2018.03.002Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2095881118300210?via%3DihubCitation Count: 15
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016RESTRICTEDTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Citation Count: 26
-
OPENTitle: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signalingJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 46End Page: 46Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1295-1Best OA location URL: https://www.nature.com/articles/s41419-018-1295-1.pdfCitation Count: 76
- Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial2015OPENTitle: Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 595End Page: 605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00008-3Citation Count: 186
- Stiripentol for the treatment of super-refractory status epilepticus2015RESTRICTEDTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Citation Count: 44
- Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”2013RESTRICTEDTitle: Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 4Start Page: e5End Page: e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.09.042Citation Count: 14
-
OPENTitle: Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page: 1930End Page: 1939Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.30238Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12254929/Citation Count: 4
-
OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26469Citation Count: 2
- Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.2014RESTRICTEDTitle: Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 592End Page: 602Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000167Citation Count: 25
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://doaj.org/article/8d8cf4f9837744e3b7e12b8b5fafeecfCitation Count: 50
- Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease2017RESTRICTEDTitle: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 2Start Page: 427End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13223Citation Count: 55
-
OPENTitle: SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis studyJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 123Issue #: 10Start Page: e2517709123End Page: e2517709123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2517709123Best OA location URL: https://doi.org/10.1073/pnas.2517709123Citation Count: 1
-
OPENTitle: Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 874End Page: 878Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14068Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14068Citation Count: 13